A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Alector, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 16,700 shares of ALEC stock, worth $30,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,700
Previous 8,400 98.81%
Holding current value
$30,895
Previous $38,000 102.63%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.34 - $6.58 $849,702 - $1.29 Million
195,784 New
195,784 $914,000
Q1 2024

May 15, 2024

BUY
$5.69 - $8.08 $177,351 - $251,845
31,169 New
31,169 $187,000
Q3 2023

Nov 14, 2023

SELL
$5.2 - $8.77 $1.11 Million - $1.87 Million
-213,191 Reduced 96.4%
7,960 $51,000
Q2 2023

Aug 14, 2023

BUY
$5.86 - $7.93 $1.3 Million - $1.75 Million
221,151 New
221,151 $1.33 Million
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $2.79 Million - $3.87 Million
405,014 Added 471.91%
490,838 $4.53 Million
Q3 2022

Nov 14, 2022

SELL
$8.19 - $13.2 $295,274 - $475,899
-36,053 Reduced 29.58%
85,824 $812,000
Q2 2022

Aug 15, 2022

BUY
$7.65 - $14.24 $129,545 - $241,140
16,934 Added 16.14%
121,877 $1.24 Million
Q1 2022

May 16, 2022

BUY
$13.02 - $20.78 $963,506 - $1.54 Million
74,002 Added 239.17%
104,943 $1.5 Million
Q4 2021

Feb 14, 2022

SELL
$19.35 - $25.54 $2.77 Million - $3.66 Million
-143,229 Reduced 82.24%
30,941 $638,000
Q3 2021

Nov 15, 2021

SELL
$21.65 - $39.49 $2.61 Million - $4.77 Million
-120,727 Reduced 40.94%
174,170 $3.98 Million
Q2 2021

Aug 16, 2021

BUY
$15.5 - $22.48 $3.93 Million - $5.7 Million
253,608 Added 614.23%
294,897 $6.14 Million
Q1 2021

May 17, 2021

SELL
$14.84 - $22.23 $2.42 Million - $3.63 Million
-163,372 Reduced 79.83%
41,289 $832,000
Q4 2020

Feb 16, 2021

SELL
$9.4 - $16.7 $836,628 - $1.49 Million
-89,003 Reduced 30.31%
204,661 $3.1 Million
Q3 2020

Nov 16, 2020

BUY
$10.54 - $24.96 $2.59 Million - $6.12 Million
245,376 Added 508.15%
293,664 $3.09 Million
Q2 2020

Aug 14, 2020

BUY
$21.87 - $33.11 $142,483 - $215,711
6,515 Added 15.6%
48,288 $1.18 Million
Q1 2020

May 15, 2020

SELL
$16.25 - $35.28 $3,363 - $7,302
-207 Reduced 0.49%
41,773 $1.01 Million
Q2 2019

Aug 14, 2019

BUY
$16.26 - $26.42 $682,594 - $1.11 Million
41,980 New
41,980 $798,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $153M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.